The molecular cloning of the t(5;10)(q33; q22) associated with atypical chronic myeloid leukemia (CML) is reported. Fluorescence in situ hybridization (FISH), Southern blot, and reverse transcriptase-polymerase chain reaction analysis demonstrated that the translocation resulted in an H4/platelet-derived growth factor receptor βR (PDGFβR) fusion transcript that incorporated 5′ sequences from H4 fused in frame to 3′ PDGFβR sequences encoding the transmembrane, WW-like, and tyrosine kinase domains. FISH combined with immunophenotype analysis showed that t(5;10)(q33;q22) was present in CD13 + and CD14 + cells but was not observed in CD3 + or CD19 + cells. H4 has previously been implicated in pathogenesis of papillary thyroid carcinoma as a fusion partner of RET. The H4/RET fusion incorporates 101 amino acids of H4, predicted to encode a leucine zipper dimerization domain, whereas the H4/PDGFβR fusion incorporated an additional 267 amino acids of H4. Retroviral transduction of H4/PDGFβR, but not a kinase-inactive mutant, conferred factor-independent growth to Ba/F3 cells and caused a T-cell lymphoblastic lymphoma in a murine bone marrow transplantation assay of transformation. Mutational analysis showed that the amino-terminal H4 leucine zipper domain (amino acids 55-93), as well as H4 amino acids 101 to 386, was required for efficient induction of factor-independent growth of Ba/F3 cells. Tryptophan-to-alanine substitutions in the PDGFβR WW-like domain at positions 566/593, or tyrosine-to-phenylalanine substitutions at PDGFβR positions 579/581 impaired factor-independent growth of Ba/F3 cells. H4/PDGFβR is an oncoprotein expressed in t(5;10)(q33;q22) atypical CML and requires dimerization motifs in the H4 moiety, as well as residues implicated in signal transduction by PDGFβR, for efficient induction of factor-independent growth of Ba/F3 cells.
H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22) / J. Schwaller, E. Anastasiadou, D. Cain, J. Kutok, S. Wojiski, I.R. Williams, R. Lastarza, B. Crescenzi, D.W. Sternberg, P. Andreasson, R. Schiavo, S. Siena, C. Mecucci, D. Gary Gilliland. - In: BLOOD. - ISSN 0006-4971. - 97:12(2001), pp. 3910-3918.
H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22)
S. Siena;
2001
Abstract
The molecular cloning of the t(5;10)(q33; q22) associated with atypical chronic myeloid leukemia (CML) is reported. Fluorescence in situ hybridization (FISH), Southern blot, and reverse transcriptase-polymerase chain reaction analysis demonstrated that the translocation resulted in an H4/platelet-derived growth factor receptor βR (PDGFβR) fusion transcript that incorporated 5′ sequences from H4 fused in frame to 3′ PDGFβR sequences encoding the transmembrane, WW-like, and tyrosine kinase domains. FISH combined with immunophenotype analysis showed that t(5;10)(q33;q22) was present in CD13 + and CD14 + cells but was not observed in CD3 + or CD19 + cells. H4 has previously been implicated in pathogenesis of papillary thyroid carcinoma as a fusion partner of RET. The H4/RET fusion incorporates 101 amino acids of H4, predicted to encode a leucine zipper dimerization domain, whereas the H4/PDGFβR fusion incorporated an additional 267 amino acids of H4. Retroviral transduction of H4/PDGFβR, but not a kinase-inactive mutant, conferred factor-independent growth to Ba/F3 cells and caused a T-cell lymphoblastic lymphoma in a murine bone marrow transplantation assay of transformation. Mutational analysis showed that the amino-terminal H4 leucine zipper domain (amino acids 55-93), as well as H4 amino acids 101 to 386, was required for efficient induction of factor-independent growth of Ba/F3 cells. Tryptophan-to-alanine substitutions in the PDGFβR WW-like domain at positions 566/593, or tyrosine-to-phenylalanine substitutions at PDGFβR positions 579/581 impaired factor-independent growth of Ba/F3 cells. H4/PDGFβR is an oncoprotein expressed in t(5;10)(q33;q22) atypical CML and requires dimerization motifs in the H4 moiety, as well as residues implicated in signal transduction by PDGFβR, for efficient induction of factor-independent growth of Ba/F3 cells.File | Dimensione | Formato | |
---|---|---|---|
3910.full.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
495.97 kB
Formato
Adobe PDF
|
495.97 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.